Pharmacotherapies Targeting GABA-Glutamate Neurotransmission for Treatment-Resistant Depression

Pharmacotherapies Targeting GABA-Glutamate Neurotransmission for Treatment-Resistant Depression

Treatment-resistant depression (TRD) is a term used to describe a particular type of major depressive disorder (MDD). There is no consensus about what defines TRD, with various studies describing between 1 and 4 failures of antidepressant therapies, with or without electroconvulsive therapy (ECT). T...

Full description

Bibliographic Details
Main Authors: Courtney M. Vecera, Alan C. Courtes, Gregory Jones, Jair C. Soares, Rodrigo Machado-Vieira
Format: Article
Language:English
Published: MDPI AG 2023-11-01
Series:Pharmaceuticals
Subjects:
antidepressants
depression
treatment-resistant depression
treatment
targets
GABA
Online Access:https://www.mdpi.com/1424-8247/16/11/1572

Internet

https://www.mdpi.com/1424-8247/16/11/1572

Similar Items